Literature DB >> 11004014

Baroreflexes prevent neurally induced sodium retention in angiotensin hypertension.

T E Lohmeier1, J R Lohmeier, A Haque, D A Hildebrandt.   

Abstract

Recent studies indicate that renal sympathetic nerve activity is chronically suppressed during ANG II hypertension. To determine whether cardiopulmonary reflexes and/or arterial baroreflexes mediate this chronic renal sympathoinhibition, experiments were conducted in conscious dogs subjected to unilateral renal denervation and surgical division of the urinary bladder into hemibladders to allow separate 24-h urine collection from denervated (Den) and innervated (Inn) kidneys. Dogs were studied 1) intact, 2) after thoracic vagal stripping to eliminate afferents from cardiopulmonary and aortic receptors [cardiopulmonary denervation (CPD)], and 3) after subsequent denervation of the carotid sinuses to achieve CPD plus complete sinoaortic denervation (CPD + SAD). After control measurements, ANG II was infused for 5 days at a rate of 5 ng. kg(-1). min(-1). In the intact state, 24-h control values for mean arterial pressure (MAP) and the ratio for urinary sodium excretion from Den and Inn kidneys (Den/Inn) were 98 +/- 4 mmHg and 1.04 +/- 0.04, respectively. ANG II caused sodium retention and a sustained increase in MAP of 30-35 mmHg. Throughout ANG II infusion, there was a greater rate of sodium excretion from Inn vs. Den kidneys (day 5 Den/Inn sodium = 0.51 +/- 0.05), indicating chronic suppression of renal sympathetic nerve activity. CPD and CPD + SAD had little or no influence on baseline values for either MAP or the Den/Inn sodium, nor did they alter the severity of ANG II hypertension. However, CPD totally abolished the fall in the Den/Inn sodium in response to ANG II. Furthermore, after CPD + SAD, there was a lower, rather than a higher, rate of sodium excretion from Inn vs. Den kidneys during ANG II infusion (day 5 Den/Inn sodium = 2.02 +/- 0.14). These data suggest that cardiac and/or arterial baroreflexes chronically inhibit renal sympathetic nerve activity during ANG II hypertension and that in the absence of these reflexes, ANG II has sustained renal sympathoexcitatory effects.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11004014     DOI: 10.1152/ajpregu.2000.279.4.R1437

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  20 in total

1.  Time-dependent changes in autonomic control of splanchnic vascular resistance and heart rate in ANG II-salt hypertension.

Authors:  Marcos T Kuroki; Pilar A Guzman; Gregory D Fink; John W Osborn
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-23       Impact factor: 4.733

Review 2.  Implantable device therapy for the treatment of resistant hypertension.

Authors:  Nikhil Joshi; Jeremy Taylor; John D Bisognano
Journal:  J Cardiovasc Transl Res       Date:  2009-03-04       Impact factor: 4.132

3.  Angiotensin II infusion model of hypertension: is there an important sympathetic component?

Authors:  Thomas E Lohmeier
Journal:  Hypertension       Date:  2012-01-23       Impact factor: 10.190

Review 4.  The baroreflex as a long-term controller of arterial pressure.

Authors:  Thomas E Lohmeier; Radu Iliescu
Journal:  Physiology (Bethesda)       Date:  2015-03

Review 5.  Carotid Baroreceptor Stimulation in Resistant Hypertension and Heart Failure.

Authors:  Gino Seravalle; Guido Grassi
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-03-27

Review 6.  Lowering of blood pressure by chronic suppression of central sympathetic outflow: insight from prolonged baroreflex activation.

Authors:  Thomas E Lohmeier; Radu Iliescu
Journal:  J Appl Physiol (1985)       Date:  2012-07-12

7.  Contribution of pressure natriuresis to control of total body sodium: balance studies in freely moving dogs.

Authors:  E Seeliger; E Safak; P B Persson; H W Reinhardt
Journal:  J Physiol       Date:  2001-12-15       Impact factor: 5.182

8.  Systemic and renal-specific sympathoinhibition in obesity hypertension.

Authors:  Thomas E Lohmeier; Radu Iliescu; Boshen Liu; Jeffrey R Henegar; Christine Maric-Bilkan; Eric D Irwin
Journal:  Hypertension       Date:  2011-12-19       Impact factor: 10.190

Review 9.  The role of the sympathetic nervous system in obesity-related hypertension.

Authors:  Alexandre A da Silva; Jussara do Carmo; John Dubinion; John E Hall
Journal:  Curr Hypertens Rep       Date:  2009-06       Impact factor: 5.369

10.  Comparison of arterial pressure and plasma ANG II responses to three methods of subcutaneous ANG II administration.

Authors:  Marcos T Kuroki; Gregory D Fink; John W Osborn
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-07-03       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.